These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 20691267

  • 1. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.
    Baillie LW, Huwar TB, Moore S, Mellado-Sanchez G, Rodriguez L, Neeson BN, Flick-Smith HC, Jenner DC, Atkins HS, Ingram RJ, Altmann DM, Nataro JP, Pasetti MF.
    Vaccine; 2010 Sep 24; 28(41):6740-8. PubMed ID: 20691267
    [Abstract] [Full Text] [Related]

  • 2. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
    Suryanarayana N, Verma M, Thavachelvam K, Saxena N, Mankere B, Tuteja U, Hmuaka V.
    Appl Microbiol Biotechnol; 2016 Oct 24; 100(19):8439-51. PubMed ID: 27364624
    [Abstract] [Full Text] [Related]

  • 3. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
    Varshney A, Kumar M, Nagar DP, Pal V, Goel AK.
    Biologicals; 2019 Sep 24; 61():38-43. PubMed ID: 31416791
    [Abstract] [Full Text] [Related]

  • 4. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses.
    Abdous M, Hasannia S, Salmanian AH, Shahryar Arab S, Shali A, Alizadeh GA, Hajizadeh A, Khafri A, Mohseni A.
    Immunopharmacol Immunotoxicol; 2019 Feb 24; 41(1):25-31. PubMed ID: 30621469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S, Somani VK, Gupta S, Garg R, Bhatnagar R.
    Med Microbiol Immunol; 2019 Apr 24; 208(2):185-195. PubMed ID: 30671633
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML, Crowe SR, Kurella S, Teryzan S, Cao B, Ballard JD, James JA, Farris AD.
    Infect Immun; 2009 Jan 24; 77(1):162-9. PubMed ID: 18981257
    [Abstract] [Full Text] [Related]

  • 9. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.
    Infect Immun; 2007 Nov 24; 75(11):5425-33. PubMed ID: 17646360
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lethal factor antibodies contribute to lethal toxin neutralization in recipients of anthrax vaccine precipitated.
    Dumas EK, Garman L, Cuthbertson H, Charlton S, Hallis B, Engler RJM, Choudhari S, Picking WD, James JA, Farris AD.
    Vaccine; 2017 Jun 08; 35(26):3416-3422. PubMed ID: 28504191
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S, Hinchcliffe M, Petrie CR, Warwood SJ, Tino WT, Williams MS, Stenz JP, Cheff A, Richardson C.
    Vaccine; 2006 May 01; 24(18):3953-63. PubMed ID: 16530302
    [Abstract] [Full Text] [Related]

  • 14. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against B. anthracis Spores and Toxin.
    Majumder S, Das S, Somani VK, Makam SS, Kingston JJ, Bhatnagar R.
    Front Immunol; 2019 May 01; 10():498. PubMed ID: 30941133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The early humoral immune response to Bacillus anthracis toxins in patients infected with cutaneous anthrax.
    Brenneman KE, Doganay M, Akmal A, Goldman S, Galloway DR, Mateczun AJ, Cross AS, Baillie LW.
    FEMS Immunol Med Microbiol; 2011 Jul 01; 62(2):164-72. PubMed ID: 21401726
    [Abstract] [Full Text] [Related]

  • 18. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.
    Devera TS, Aye LM, Lang GA, Joshi SK, Ballard JD, Lang ML.
    Infect Immun; 2010 Apr 01; 78(4):1610-7. PubMed ID: 20123711
    [Abstract] [Full Text] [Related]

  • 19. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
    Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.
    Infect Immun; 2007 Apr 01; 75(4):1827-34. PubMed ID: 17145938
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.